Quest PharmaTech, Inc. (QPT.V)
0.02
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 16:00
Quest PharmaTech Debt to Equity Ratio : 0.0378 for Jan. 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| January 31, 2026 | 0.0378 |
| October 31, 2025 | 0.0433 |
| July 31, 2025 | 0.0456 |
| April 30, 2025 | 0.0453 |
| January 31, 2025 | 0.0467 |
| October 31, 2024 | 0.0432 |
| July 31, 2024 | 0.0435 |
| April 30, 2024 | 0.0449 |
| January 31, 2024 | 0.0432 |
| October 31, 2023 | 0.0399 |
| July 31, 2023 | 0.0387 |
| April 30, 2023 | 0.0313 |
| January 31, 2023 | 0.012 |
| October 31, 2022 | 0.0114 |
| July 31, 2022 | 0.0112 |
| April 30, 2022 | 0.0112 |
| January 31, 2022 | 0.0057 |
| October 31, 2021 | 0.0016 |
| July 31, 2021 | 0.0002 |
| April 30, 2021 | 0.0003 |
| January 31, 2021 | 0.0017 |
| October 31, 2020 | 0.0028 |
| July 31, 2020 | 0.0007 |
| April 30, 2020 | 0.0008 |
| January 31, 2020 | -0.1786 |
| Date | Value |
|---|---|
| October 31, 2019 | -0.0078 |
| July 31, 2019 | -0.0094 |
| April 30, 2019 | -0.0104 |
| January 31, 2019 | 0.00 |
| October 31, 2018 | 0.00 |
| July 31, 2018 | 0.00 |
| April 30, 2018 | 0.00 |
| January 31, 2018 | 0.00 |
| October 31, 2017 | 0.00 |
| July 31, 2017 | 0.00 |
| April 30, 2017 | 0.00 |
| January 31, 2017 | 0.00 |
| October 31, 2016 | 0.00 |
| July 31, 2016 | 0.00 |
| April 30, 2016 | -4.900 |
| January 31, 2016 | -5.452 |
| October 31, 2015 | -1.172 |
| July 31, 2015 | -0.5699 |
| April 30, 2015 | -0.5173 |
| January 31, 2015 | -0.4734 |
| October 31, 2014 | -0.4756 |
| July 31, 2014 | -0.4406 |
| April 30, 2014 | -0.3112 |
| January 31, 2014 | -0.3606 |
| October 31, 2013 | -0.7761 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Kane Biotech, Inc. | -1.352 |
| BriaCell Therapeutics Corp. | 0.00 |
| Vaxil Bio Ltd. | 0.00 |
| Waverley Pharma, Inc. | -1.299 |
| Goldcoast Resource Corp. | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 27.75M |
| Total Liabilities (Quarterly) | 1.329M |
| Shareholders Equity (Quarterly) | 26.43M |
| Current Ratio | 0.0248 |